A change in GSH/GSSG can reflect tissue injury, metabolic limitation, compensatory defense, treatment response, or a combination of these processes
Pertea, M
A smaller factor is absorption at the injection site
Other frequently reported side effects associated with semaglutide may include headache, abdominal pain, nasopharyngitis, dizziness, gastroenteritis, constipation, and GERD.[2] Semaglutide has a boxed warning, or a serious safety warning by the FDA, for the risk of thyroid C-cell tumors.[2] Additional safety warnings and precautions are acute pancreatitis, gall bladder disease, kidney injury, increased heart rate, and hypersensitivity reactions
Orforglipron, an oral small-molecule GLP-1 receptor agonist for obesity treatment